CompanyDrug

Luye Pharma’s BA2101 Begins Phase I Clinical Trial for Allergic Diseases

CompanyDrug

CDE Accepts Clinical Trial Filing for Ranok’s First-in-Class BRD4 Degradation Drug RNK05047

CompanyDrug

Junshi Biosciences and Coherus Report Positive JUPITER-02 Trial Results for NPC Treatment

CompanyDeals

Eyenovia Partners with Formosa Pharmaceuticals for Ophthalmic Therapeutics

CompanyDeals

Brii Biosciences Publishes Positive Phase II Results for HBV Treatment

CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Approval for SHR-A1921 Clinical Study

CompanyMedical Device

Grand Pharma Completes First Atrial Fibrillation Treatment with HeartLight X3

CompanyDrug

Zelgen’s ZG2001 and ZG0895 Clinical Trials Approved by NMPA

CompanyDrug

Innovent Biologics Initiates Phase II Study for IBI311 in Thyroid-Associated Ophthalmopathy

CompanyDeals

Hygea Medtech Secures Series D Funding for Oncology Device Expansion

CTI Acquires Vectoring Pharmatech to Expand Pharmacy CMC Research
CompanyDeals

CTI Acquires Vectoring Pharmatech to Expand Pharmacy CMC Research

CompanyDeals

Shenzhen United Family Hospital Partners with GBA Medical Delegation